Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Interventional Neurology Market To Surpass US$ 2.7 Billion By 2024 - Coherent Market InsightsInterventional Neurology Market Report Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
The Global Interventional Neurology Market is projected to reach USD 2,684.6 million by 2024 Recommendations from the American Heart Association and American Stroke Association to use neurointerventional devices in stroke is a major factor boosting market growth. Increasing demand for minimally invasive procedures is one of the prime factors driving adoption of neurointerventional devices worldwide. The American Heart Association and American Stroke In 2015, Medtronic PLC acquired Lazarus Effect, a California-based medical device company engaged in development of acute ischemic stroke products for around US$ 100 million. Lazarus Effect was acquired with an aim to enhance Medtronic's neurovascular business and related portfolio. Browse Research Report: https://www.coherentmarketinsights.com/ Food and Drug Administration (FDA) expanded the approval of solitaire stent retriever device of Medtronic PLC, which is intended for stroke-related disability. This device can be used by patients suffering from large vessel occlusion, proximal anterior circulation, and smaller core infarcts to reduce paralysis, and other stroke-related disabilities. CE approved EmboTrap stent retriever platform, the EmboTrap II Revascularization Device from Neuravi Ltd., which is intended for easy removal of different lengths clots * The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology. Request a sample copy of this report: https://www.coherentmarketinsights.com/ Key takeaways of the market include: There are a range of neurointerventional devices such as embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices, embolic protection devices, and flow diverter devices available in the market. Embolic coils was the largest segment and accounted for 32.5% share (in terms of revenue) in 2015. This is mainly due to these being the mainstay of endovascular treatment for brain aneurysms and hemorrhage. In 2015, North America dominated the global Interventional neurology market, with the contribution of the region estimated at US$ 701.9 million. Increasing incidence rate of brain aneurysm and ischemic strokes along with favorable government policies such as Medicare and Medicaid is expected to bolster sales of interventional neurology devices over the forecast period. Penumbra 3D Revascularization Device Trial successfully met the primary trial endpoints in 2016 Buy-Now this research report: https://www.coherentmarketinsights.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|